Rankings
▼
Calendar
GUTS Q3 2024 Earnings — Fractyl Health, Inc. Common Stock Revenue & Financial Results | Market Cap Arena
GUTS
Fractyl Health, Inc. Common Stock
$35M
Q3 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$14,000
-61.1% YoY
Gross Profit
$7,000
50.0% margin
Operating Income
-$24M
-169957.1% margin
Net Income
-$23M
-165521.4% margin
EPS (Diluted)
$-0.48
QoQ Revenue Growth
-67.4%
Cash Flow
Operating Cash Flow
-$18M
Free Cash Flow
-$18M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$127M
Total Liabilities
$77M
Stockholders' Equity
$50M
Cash & Equivalents
$85M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$14,000
$36,000
-61.1%
Gross Profit
$7,000
-$73,000
+109.6%
Operating Income
-$24M
-$14M
-71.5%
Net Income
-$23M
-$16M
-47.2%
← FY 2024
All Quarters
Q4 2024 →